Medicinal cannabis: Approval process causing delays, says firm

Red tape is strangling the development and sale of medicinal cannabis products, according to one firm. (File photo) NZX-listed Cannasouth’s chief executive says the regulatory pathway is difficult and takes a long time. Photo: 123 RF NZX-listed Cannasouth, which is hoping to export products early next year, says local firms wanting approval have to jump through many hoops. Chief executive Mark Lucas said the Medicinal Cannabis Agency is assessing products it is not used to seeing, which has caused delays. “The regulatory pathway is definitely difficult, it takes a long time.” “The medicinal cannabis industry is highly complex, highly regulated…

Medicinal cannabis: Approval process causing delays, says firm Topshelf News.

source https://topshelf.news/medicinal-cannabis-approval-process-causing-delays-says-firm/